Andreessen Horowitz, better known as a16z, just closed a monster fundraise of more than $15 billion, co-founder Ben Horowitz announced Friday. To put that in perspective, it's roughly 18% of every venture dollar allocated across the entire United States last year.

That's not just big. That's "we're basically the market now" big.

Where the Money's Going

The capital is spread across several buckets: $6.75 billion for growth-stage investments, about $1.7 billion each for application and infrastructure funds, $1.176 billion dedicated to "American Dynamism," $700 million for biotech and healthcare, and roughly $3 billion for other venture initiatives.

The American Dynamism strategy is where things get interesting. It's focused squarely on defense, aerospace, manufacturing, and public infrastructure—the kind of stuff that sounds boring until you realize it's jet-powered drones and AI-guided naval vessels. The portfolio includes companies like Anduril Industries, Shield AI, and Saronic Technologies, all of which happen to be well-aligned with Pentagon priorities and U.S. national security goals.

Meanwhile, a16z is also making massive bets across the AI stack, from infrastructure and foundation models to consumer-facing applications. In recent years, the firm has aggressively backed defense technology companies including Anduril and SpaceX, riding a wave of momentum sparked by President Donald Trump's push to rebuild American military and industrial capacity.

With this latest haul, Andreessen Horowitz's total assets under management now surpass $90 billion, placing it alongside Sequoia Capital as one of the largest venture capital firms on the planet.

Trump's Military Spending Push

The timing couldn't be better for defense-focused investors. Earlier this week, defense stocks rallied after President Trump suggested the U.S. military budget could balloon from the current congressionally approved $900 billion to as much as $1.5 trillion by 2027.

Last year, Trump also turned up the heat on major defense contractors, criticizing their stock buyback programs and executive compensation while questioning whether those priorities were getting in the way of actual production.